• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on October 10, 2006September 14, 2023

Acute intussusception in infants and children as an adverse event following immunization

To improve comparability of vaccine safety data, The Brighton Collaboration Intussusception Working Group has developed a case def...
Read More
Posted on January 13, 2006September 14, 2023

Nodule at injection site as an adverse event following immunization

To improve comparability of vaccine safety data the Brighton Collaboration Local Reactions Working Group has developed a case defi...
Read More
Posted on April 13, 2004September 14, 2023

Persistent crying in infants and children as an adverse event following immunization

To improve comparability of vaccine safety data, the Persistent Crying Working Group has developed a case definition and guideline...
Read More
Posted on February 13, 2004September 14, 2023

Fever as an adverse event following immunization

Need for developing case definitions and guidelines for fatigue as an adverse event following immunization: Fatiguing illnesses...
Read More
Previous page 1 … 6 7 8

Recent Posts

  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024
  • Lessons Learned from Vaccine Safety Surveillance EffortsSeptember 3, 2024
  • Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessmentAugust 27, 2024
  • Safety by Numbers – August 2024August 14, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy